BIONTECH
OpenCalais Metadata: Ticker
OpenCalais Metadata: LegalName
Κομισιόν: Συμφωνία 500 εκατ. ευρώ για παροχή εμβολίων σε χώρες χαμηλού και μεσαίου εισοδήματος
Στις 23 Δεκεμβρίου θα δώσει το πράσινο φως η ΕΕ για την έγκριση του εμβολίου των Pfizer/BionTech
European regulator to approve Covid-19 vaccine on Dec. 23, says Bild
The European Medicines Agency (EMA) is aiming to approve the Covid-19 vaccine developed by Pfizer and BioNTech on December 23, German newspaper Bild reported on Tuesday, citing government and European Commission sources.
A new form of coronavirus discovered, the "third level of alert" declared in London
According to him, that could explain why the level of infections in that part of the country is growing faster than in other parts.
US begins COVID-19 vaccinations as its death toll passes 300,000
The United States kicked off a mass vaccination drive on Dec. 14 hoping to turn the tide on the world's biggest coronavirus outbreak, as the nation's death toll passed a staggering 300,000.
Gantar: Slovenia expects first 5,000 doses of vaccine by end-2020
Ljubljana – Slovenia has been promised to get some 5,000 doses of anti-coronavirus vaccine by the end of the year, Health Minister Tomaž Gantar told MPs in questions time in parliament on Monday. This is the vaccine developed by Pfizer and BioNTech, which is expected to be green-lighted by the European Medicines Agency on 29 December.
Pressure mounts on EU drug regulator to approve Pfizer Covid-19 vaccine
Europe's drug regulator is under increasing pressure to quickly approve the Covid-19 vaccine developed by US giant Pfizer and Germany's BioNTech, officials said, as inoculations get started in Britain and the United States.
The push underscores the frictions between regulators and governments wishing to curb the pandemic that has killed more than 1.6 million people worldwide.
US to start vaccinating as Germany returns to partial lockdown
The United States prepared to start its COVID-19 vaccination program on Dec. 14 as the nation's death toll edged towards 300,000, while Germany announced a partial lockdown over the holidays due to an explosion of cases.
AstraZeneca buying drug developer Alexion for $39 billion
Pharmaceutical company AstraZeneca says it is buying U.S. drug developer Alexion in a deal worth $39 billion.
Cambridge, England-based AstraZeneca PLC, which is involved in one of the efforts to develop a COVID-19 vaccine, said on Dec. 12 it's using a combination of cash and shares for the acquisition of Boston-based Alexion Pharmaceuticals Inc.
US poised for mass vaccine campaign as world virus toll nears 1.6 mln
The Pfizer-BioNTech COVID-19 vaccine will reach hospitals and other sites across the United States by Dec. 14 morning, a top official said Saturday, ready to be injected into the arms of millions of the most vulnerable Americans as the world's death toll approached 1.6 million.
US approves Pfizer vaccine as millions of doses begin shipping
The U.S. green-lighted the Pfizer-BioNTech Covid-19 vaccine late Dec. 11, paving the way for millions of vulnerable people to receive their shots in the world's hardest-hit country.
President Donald Trump immediately released a video on Twitter, where he hailed the news as a "medical miracle" and said the first immunizations would take place "in less than 24 hours."